PREVENTION OF BIOFILM IN HEMODIALYSIS WATER SYSTEMS
DESCRIPTION (Provided by applicant): Hemodialysis-related infections and
adverse patient outcomes continue to be associated with contaminated fluids
often arising from biofilm formation in the tubing of hemodialysis systems.
Currently available reagents to disinfect fluid delivery lines are either
hazardous to humans, unpleasant to work with, environmentally unsafe, or
corrosive to expensive hemodialysis equipment at the required contact times.
Biomedical Development Corporation is developing a unique disinfectant to
improve the quality of water and dialysate circulating through hemodialysis
systems. The disinfectant is biocidal against a broad spectrum of organisms and
operates as a biofilm reducing agent in clinical water delivery systems.
Preliminary studies demonstrate that the disinfectant is an effective
antimicrobial, even in the presence of biofilm, is nontoxic, and inexpensive to
produce. This study will involve adaptation of the disinfectant for clinical
use, and include extensive safety and efficacy testing in preparation for
approval and use in hemodialysis fluid delivery systems.
Small Business Information at Submission:
Principal Investigator:Bakul M. Bhatt
BIOMEDICAL DEVELOPMENT CORPORATION
BIOMEDICAL DEVELOPMENT CORP 500 SANDAU, STE 200 SAN ANTONIO, TX 78216
Number of Employees: